Recent advances in hemodynamic monitoring and management of the emergency critically ill patient

Current Opinion in Critical Care

Volumn 4, Issue 3, 1998, Pages 168-176

  Nicholls, Tim ^a   Shoemaker, William C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041193095     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199806000-00010     Document Type: Article

References (97)

1. Bishop MH, Shoemaker WC, Appel FI, et al.: Relationship between supranormal values, time delays, and outcome in severely traumatized patients. Crit Care Med 1993, 21:56-63.
2. Ferguson KL, Brown L: Bacteremia and sepsis. Emerg Med Clin North Am 1996, 14:185-95.
3. Shoemaker WC, Wo CCJ, Demetriades D, Belzberg H, et al.: Early physiologic patterns in acute illness and accidents. New Horiz 1996, 4:395-412.
4. Fontana JL, Welborn L, Mongan PD, Sturm P, Martin G, Bunger R: Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesth Analg 1995, 80:219-225.
5. Convertino VA: Cardiovascular consequences of bed rest: effect on maximal oxygen uptake. Med Sci Sports Exerc 1997, 29:191-196.
6. Hotchkiss RS, Karl IE: Calcium: a regulator of the inflammatory response in endotoxemia and sepsis. New Horiz 1996, 4:58-71.
7. Shapiro MJ, Mistry B: Calcium regulation and nonprotective properties of calcium in surgical ischemia. New Horiz 1996, 4:134-138.
8. Storm W, Zimmerman JJ: Magnesium deficiency and cardiogenic shock after cardiopulmonary bypasss. Ann Thorac Surg 1997, 64:572-577.
9. Simonson SG, Piantadosi CA: Near-infrared spectroscopy: clinical applications. Crit Care Clin 1996, 12:1019-1029.
10. Du Plessis AJ: Near-infrared spectroscopy for the in vivo study of cerebral hemodynamics and oxygenation. Curr Opin Pediatr 1995, 7:632-639.
11. Bellardinelli R, Beorgiou D, Barstow TJ: Near infrared spectroscopy and changes in skeletal muscle oxygenation during incremental exercise in chronic heart failure: a comparison with healthy subjects. Giornale Italiano di Cardiologia 1995, 25:715-724.
12. Ovada-Tirosh Z, Kornowski R, Walden R, Chayen D, Gavish B, Battler A, Eldar M: An integrated noninvasive system for monitoring the microcirculatory effects of vasoactive drugs: an experimental study. Microvasc Res 1997, 53:14-21.
13. Belfort MA, Mares A, Saade G, Wen T, Rokey R: Two-dimensional echocardiography and Doppler ultrasound in managing obstetric patients. Obstet Gynecol 1997, 90:326-330.
14. Gueguniad PY, Bertin-Maghit M, Hirshcauer C, Bouchard C, Vilasco B, Petit P: In the early stage of major burns, is there a correlation between survival, interleukin-6 levels and oxygen delivery and consumption? Burns 1997, 23:426-431.
15. Schiller WR, Bay RC: Hemodynamics and oxygen transport in management of burns. New Horiz 1996, 4:475-482.
16. Schiller WR, Bay RC, Garren RL, et al.: Hyperdynamic resuscitation improves survival in patients with life threatening burns. J Burn Care Rehab, in press.
17. Rady MY, Kirkman E, Cranley J, Little RA: Nociceptive somatic nerve stimulation and skeletal muscle injury modify systemic hemodynamics and oxygen transport and utilization after resuscitation from hemorrhage. Crit Care Med 1996, 24:623-630.
18. Cavaliere F, Martinelli L, Guarneri S, Varano C, Coricello F, Sciarra M, Schiavello R: Haemodynamic and metabolic effects of surface rewarming after coronary revascularization. Eur Cardiothoracic Surg 1995, 9:582-586.
19. Manthous CA, Hall JB, Olson D, Singh M, Chatlia W, Pohlman A. Kushner R, Schmidt GA, Wood LD: Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 1995, 151:10-14.
20. Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH: Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol 1995, 7:887-892.
21. Stegmayr BG: Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996, 14:94-101.
22. Intaglietta M: Whitaker Lecture 1996: microcirculation, biomedical engineering, and artificial blood. Ann Biomedi Eng 1997, 25:593-603.
23. Conners AF Jr, Speroff T, Dawson NV, Thomas C, et al.: The effectiveness of right heart catheterizaion in the initial care of critically ill patients. JAMA 1996, 276:899-897.
24. Gore JM, Goldberg RJ, Spodick DH, Alpert JS, et al.: A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest 1987, 92:721-727.
25. Zion MM, Balkin J, Rosenmann D, et al.: Use of pulmonary artery catheters in patients with acute myocardial infarction: analysis of experience in 5841 patients in the SPRINT registry. Chest 1990, 98:1331-1335.
26. Blumberg MS, Binns GS: Swan-Ganz catheter use and mortality in myocardial infarction patients. Health Care Financ Rev 1994, 15:91-103.
27. Hayes MA, Timmins AC, Yau EHS, Pallazo M, et al.: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717-1722.
28. Gattinoni L, Brazzi L, Pelosi P, et al.: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995, 333:1025-1032.
29. Young JS, Meredith JW: Does oxygen delivery-directed resuscitation worsen outcome of head Injured patients with multisystem injuries? Am Surg 1995, 61:419-423.
30. Chittock DR, Russel JA: Oxygen delivery and consumption during sepsis. Clin Chest Med 1996, 17:263-278.
31. Shoemaker WC, Appel PL, Kram HB, et al.: Prospective trial of supranormal values of survivors as therapeutic goals in high risk surgical patients. Chest 1988, 94:1176-1186.
32. Boyd O, Grounds M, Bennett D: Preoperative increase of oxygen delivery reduces mortality in high risk surgical patients. JAMA 1993, 270:2699-2704.
33. Bishop MH, Shoemaker WC, Kram HB, Ordog GJ, et al.: Prospective randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma 1995, 38:780-787.
34. Berlauk JF, Abrams JH, Gilmour IJ, et al.: Pre-operative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. Ann Surg 1991, 214:289-297.
35. Yu M, Levy MM, Smith P, et al.: Effect of maximizing oxygen delivery on mortality and mortality rates in critically ill patients: a prospective randomized controlled study. Crit Care Med 1994, 22:830-838.
36. Tuchschmidt J, Fried J, Astiz M, et al.: Evaluation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992, 102:216-220.
37. Scalea TM, Simon HM, Duncan AO, et al.: Geriatric blunt multiple trauma: improved survival in early invasive monitroing. J Trauma 1990, 30:129-136.
38. Moore FA, Haenel JB, Moore EE, et al.: Incommensurate oxygen consumption in response to maximal oxygen availability predicts postinjury oxygen failure. J Trauma 1992, 38:58-65.
39. Hankeln KB, Senker R, Schwarten JN, et al.: Evaluation of prognostic indices based on hemodynamic and oxygen transport variables in shock patients with ARDS. Crit Care Med 1987, 15:1-7.
40. Creamer JE, Edwards JD, Nightingale P: Hemodynamic and oxygen transport variables in cardiogenic shock secondary to acute myocardial infarction. Am J Cardiol 1990, 65:1297-1300.
41. Rady MY, Edwards JD, Rivers EP, et al.: Measurement of oxygen consumption after uncomplicated acute myocardial infarction. Chest 1993, 104:930-934.
42. Schultz RJ, Whitfield GF, LaMura JJ, et al.: The role of physiologic monitoring patients with fractures of the hip. J Trauma 1985, 25:309-316.
43. Boyd O, Bennett D: Enhancement of perioperative tissue perfusion as a therapeutic strategy for major surgery. New Horiz 1996, 4:453-465.
44. Shoemaker WC, Appel PL, Kram HB: Role of oxygen debt in the development of organ failure, sepsis, and death in high risk surgical patients. Chest 1992, 102:208-215.
45. Thangathurai D, Charbonnet C, Wo CCJ, Shoemaker WC, et al.: Intra-operative maintenance of tisue perfusion prevents ARDS. New Horiz 1996, 4:453-465.
46. Yu M, Takanishi D, Myers SA, Takiguchi SA, Severino R, Hasaniya N, Levy MM, McNamara JJ: Frequency of mortality and myocardial infarction during maximizing oxygen delivery: a prospective, randomized trial. Crit Care Med 1995, 23:1025-1032.
47. Yu M: Invasive and noninvasive oxygen consumption and hemodynamic monitoring in elderly surgical patients. New Horiz 1996, 4:443-452.
48. Heyland DK, Cook DJ, King D, Kernerman P, Brun-Buisson C: Maximizing oxygen delivery in critically ill patients: a methodologic appariasal of the evidence. Crit Care Med 1996, 24:517-524.
49. Taylor RW, and the Pulmonary Artery Catheter Consensus Conference: Crit Care Med 1997, 25:910-925.
50. Kirton OC, Civetta JM: Do pulmonary artery catheters alter outcome in trauma patients? New Horiz 1997, 5:222-227.
51. Shoemaker WC, Belzberg H, Wo CCJ, Milzman DP, et al.: Multicenter study of noninvasive monitoring as alternatives to invasive monitoring in early management of acutely ill emergency patients. Chest, in press.
52. Wang X, Sun H, Adamson D, et al.: An impedance cardiography system: a new design. Ann Biomed Eng 1989, 17:535-536.
53. Wang X, Van De Water JM, Sun H, et al.: Hemodynamic monitoring by impedance cardiography with an improved signal processing technique. Proc IEEE Eng Med Biol 1993, 15:699.
54. Shoemaker WC, Wo CCJ, Bishop MH, et al.: Multicenter trial of a new thoracic bioimpedance device for cardiac output estimation. Crit Care Med 1994, 22:1907.
55. Shoemaker WC, Wo CCJ, Bishop MH, et al.: Noninvasive physiologic monitoring of high risk surgical patients. Arch Surg 1996, 131:732-737.
56. Hinshaw LB: Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996, 24:1072-1078.
57. Maier RV, Bulger EM: Endothelial changes after shock and injury. New Horiz 1996, 4:211-223.
58. Drexler H: Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997, 39:287-324.
59. McCuskey RS: The microcirculation during endotoxemia. Cardiovasc Res 1996, 32:752-763.
60. Verhoef J, Mattson E: The role of cytokines in gram-positive bacterial shcok. Trends Microbiol 1995, 3:136-140.
61. Wolf JE, Rabinowitz LG: Streptococcal toxic shock-like syndrome. Arch Dermatol 1995, 131:73-77.
62. Spencer RC: Invasive streptococci. Eur J Clin Microbiol Infect Dis 1995, 14(suppl 1):S26-S32.
63. Bronze MS, Dale JB: The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci 1996, 311:41-54.
64. Calandra T, Bucala R: Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflammation 1995-6, 47:39-51.
65. Bertolini A: The opioid/anti-opioid balance in shock: a new target for theapy in resuscitation. Resuscitation 1995, 30:29-42.
66. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, et al.: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995, 199:934-941.
67. Zivot JB, Hoffman WD: Pathogenic effects of endotoxin. New Horiz 3:267-275.
68. Glauser MP: The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 1996, 52(suppl 2):9-17.
69. Verhoef J, Hustinx WM, Frasa H, Hoepelman AI: Issues in the adjunct therapy of severe sepsis. J Antimicrob Chemother 1996, 38:167-182.
70. Opal SM, Fisher Jr CJ, Dhainaut JA, Vincent JL, et al.: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit Care Med 1997, 25:1115-1123.
71. Quezado ZM, Banks SM, Natanson C: New strategies for combatting sepsis: the magic bullets missed the mark...but the search continues. Trends Biotechnol 1995, 13:56-63.
72. Cohen J, Heumann D. Glauser MP: Do monoclonal antibodies and anti-cytokines still have a future in infectious diseases? Am J Med 1995, 99:45S-52S.
73. van der Poll T, Lowry SF: TNF in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 1995, 3:1-12.
74. Dries DJ: Hypotension resuscitation. Shock 1996, 6:311-316.
75. Pruitt JH, Copeland EM 3rd, Moldawer LL: IL-1 and IL-1 antagonism in sepsis, SIRS, and septic shock. Shock 1995, 3:235-251.
76. Schletter J, Heine H, Ulmer AJ, Rietschel ET: Molecular mechanisms of endotoxin activity. Arch Microbiol 1995, 164:383-389.
77. Williams G, Girior BP: Regulation of cytokine gene expression: TNF, IL-1, and the emerging biology of cytokine receptors. New Horiz 1995, 3:276-287.
78. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Ann Rev Immunol 1995, 13:437-457.
79. Estrov Z, Kurzrock R, Talpaz M: IL-1 and its inhibitors: implications for disease biology and therapy. Cancer Treat Res 1995, 80:51-82.
80. Redl H, Schlag G, Baharami S, Yao YM: Animal models as the basis of pharmacologic intervention in trauma and sepsis patients. World J Surg 1996, 20:487-492.
81. Meadow W, Rudinsky B: Inflammatory mediators and neonatal sepsis. Rarely has so little been known by so many about so much. Clin Perinatol 1995, 22:519-536.
82. Harris BH, Gelfand JA: The immune response to trauma. Semin Pediat Surg 1995, 4:77-82.
83. Waxman K: Shock: ischemia, reperfusion, and inflammation. New Horiz 1996, 4:153-160.
84. Payer D: Nitric oxide in sepsis. Clin Chest Med 1996, 17:333-350.
85. Thiemmermann C: Nitric oxide and septic shock. Gen Pharmacol 1997, 29:159-166.
86. Wolfe TA, Dasta JF: Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann Pharmacother 1995, 29:36-46.
87. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 1997, 7:235-246.
88. Battistini B, Forget MA, Laight D: Potential roles for endothelins in SIRS with a particular relationship to cytokines. Shock 1996, 5:167-183.
89. Abu-Zidan FM, Walther S, Lennquist S: BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs. Pharmacol Toxicol 1996, 78:23-27.
90. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F: Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996, 81:1449-1453.
91. Baxter F: Septic shock. Can J Anaesth 1997, 44:59-72.
92. Carcillo JA, Cunnion RE: Septic shock. Crit Care Clin 1997, 13:553-574.
93. Kilbourn RG, Traber DL, Szabo C: Nitric oxide and shock. Dis Mon 1997, 43:277-348.
94. Toney JF, Parker MM: New perspectives on the management of septic shock in the cancer patient Infect Dis Clin North Am 1996, 10:239-253.
95. Brady AJ: Nitric oxide, myocardial failure and septic shock. Int J Cardiol 1995, 50:269-272.
96. Meier-Hellmann A, Reinhart K: Effects of catecholamines on regional perfusion and oxygenation in critically ill patients. Acta Anaesthesiol Scand 1995, 107(suppl):239-248.
97. Michie HR: Metabolism of sepsis and multiple organ failure. World J Surg 1996, 20:460-464.